RESUMEN
We describe a rare case of severe disseminated monkeypox (MPox) virus infection complicated by peritonitis in a 44-year-old man living with well-controlled HIV. The patient was successfully treated with tecovirimat without requiring surgery. MPox should be considered in the differential diagnosis of non-bacterial peritonitis in patients at risk of infection.
Asunto(s)
Mpox , Peritonitis , Masculino , Humanos , Adulto , Monkeypox virus , Peritonitis/diagnóstico , Peritonitis/tratamiento farmacológico , Peritonitis/etiología , Benzamidas , Diagnóstico DiferencialAsunto(s)
Cirugía Bariátrica/efectos adversos , Complicaciones Posoperatorias/etiología , Encefalopatía de Wernicke/etiología , Femenino , Humanos , Imagen por Resonancia Magnética , Síndromes de Malabsorción/complicaciones , Persona de Mediana Edad , Obesidad Mórbida/cirugía , Complicaciones Posoperatorias/diagnóstico por imagen , Tiamina/administración & dosificación , Factores de Tiempo , Complejo Vitamínico B/administración & dosificación , Encefalopatía de Wernicke/diagnóstico por imagenRESUMEN
Rationale: Given the paucity of effective treatments for idiopathic pulmonary fibrosis (IPF), new insights into the deleterious mechanisms controlling lung fibroblast activation, the key cell type driving the fibrogenic process, are essential to develop new therapeutic strategies. TGF-ß (transforming growth factor-ß) is the main profibrotic factor, but its inhibition is associated with severe side effects because of its pleiotropic role. Objectives: To determine if downstream noncoding effectors of TGF-ß in fibroblasts may represent new effective therapeutic targets whose modulation may be well tolerated. Methods: We investigated the whole noncoding fraction of TGF-ß-stimulated lung fibroblast transcriptome to identify new genomic determinants of lung fibroblast differentiation into myofibroblasts. Differential expression of the long noncoding RNA (lncRNA) DNM3OS (dynamin 3 opposite strand) and its associated microRNAs (miRNAs) was validated in a murine model of pulmonary fibrosis and in IPF tissue samples. Distinct and complementary antisense oligonucleotide-based strategies aiming at interfering with DNM3OS were used to elucidate the role of DNM3OS and its associated miRNAs in IPF pathogenesis. Measurements and Main Results: We identified DNM3OS as a fibroblast-specific critical downstream effector of TGF-ß-induced lung myofibroblast activation. Mechanistically, DNM3OS regulates this process in trans by giving rise to three distinct profibrotic mature miRNAs (i.e., miR-199a-5p/3p and miR-214-3p), which influence SMAD and non-SMAD components of TGF-ß signaling in a multifaceted way. In vivo, we showed that interfering with DNM3OS function not only prevents lung fibrosis but also improves established pulmonary fibrosis. Conclusions: Pharmacological approaches aiming at interfering with the lncRNA DNM3OS may represent new effective therapeutic strategies in IPF.
Asunto(s)
Fibroblastos/metabolismo , Fibrosis Pulmonar Idiopática/genética , ARN Largo no Codificante/genética , Factor de Crecimiento Transformador beta/metabolismo , Animales , Caveolina 1/metabolismo , Fibrosis Pulmonar Idiopática/metabolismo , Ratones , MicroARNs/metabolismo , Miofibroblastos/metabolismo , Transducción de Señal , Proteínas Smad/metabolismo , Vía de Señalización WntAsunto(s)
Fibrosis Endomiocárdica/diagnóstico por imagen , Fibrosis Endomiocárdica/etiología , Síndrome Hipereosinofílico/complicaciones , Síndrome Hipereosinofílico/diagnóstico por imagen , Anciano , Ecocardiografía , Fibrosis Endomiocárdica/cirugía , Femenino , Humanos , Imagen por Resonancia MagnéticaAsunto(s)
Anticuerpos Monoclonales Humanizados/uso terapéutico , Antirreumáticos/efectos adversos , Artritis Reumatoide/tratamiento farmacológico , Sarcoidosis Pulmonar/inducido químicamente , Factor de Necrosis Tumoral alfa/antagonistas & inhibidores , Disnea/etiología , Femenino , Humanos , Pulmón/diagnóstico por imagen , Persona de Mediana Edad , Sarcoidosis/inducido químicamente , Sarcoidosis Pulmonar/complicaciones , Sarcoidosis Pulmonar/diagnóstico por imagen , Tomografía Computarizada por Rayos XRESUMEN
Capsule endoscope aspiration is an increasingly reported complication, potentially responsible for respiratory distress and asphyxia. This adverse event is primarily managed by rigid bronchoscopy when spontaneous expulsion does not occur. This complication is all the more detrimental to patients as it can delay or jeopardize further digestive exploration. We report direct repositioning of the capsule in the stomach at the same time as bronchoscopy, thus making second-line gastrointestinal endoscopy needless.
Asunto(s)
Asfixia/cirugía , Bronquios/cirugía , Broncoscopía/métodos , Endoscopios en Cápsulas , Cuerpos Extraños/cirugía , Aspiración Respiratoria/cirugía , Anciano , Asfixia/diagnóstico , Asfixia/etiología , Humanos , Masculino , Radiografía Torácica , Aspiración Respiratoria/complicaciones , Aspiración Respiratoria/diagnósticoRESUMEN
BACKGROUND: Data concerning phenotypes in bronchiectasis are scarce. OBJECTIVE: The aim of this study was to describe the clinical, functional and microbiological phenotypes of patients with bronchiectasis. METHODS: A monocentric retrospective study in a university hospital in France was conducted over 10 years (2002-2012). Non-cystic fibrosis patients with tomographic confirmation of bronchiectasis were included. The clinical, functional and microbiological data of patients were analyzed relying on the underlying etiology. RESULTS: Of the 311 included patients, an etiology was found for 245 of them. At the time of diagnosis, the median age was 61 years and the mean FEV1 was 63% of predicted. The main causes of bronchiectasis were post-infectious (50%, mostly related to tuberculosis), chronic obstructive pulmonary disease (COPD; 13%) and idiopathic (11%). Other causes were immune deficiency (6%), asthma (4%), autoimmunity (3%), tumor (2%) and other causes (4%). The comparison of phenotypic traits shows significant differences between COPD, congenital and idiopathic groups in term of sex (p = 0.0175), tobacco status (p < 0.0001), FEV1 (p = 0.0412) and age at diagnosis (p < 0.001), Pseudomonas aeruginosa (PA) colonization (p = 0.0276) and lobectomy (0.0093). Functional follow-up was available in 30% of patients with a median duration of 2.7 years. Presence of PA was associated with a lower median FEV1 at diagnosis (43% p < 0.003) but not with a faster rate of decline in FEV1. CONCLUSION: Distinctive clinical, functional and microbiological features were found for idiopathic, congenital and COPD-related bronchiectasis. A prospective follow-up of these subgroups is necessary to validate their relevance in the management of bacterial colonization and specific complications of these bronchiectases.